Moreover, high MET overexpression with a 3+ immunoscore (IHC3+) by immunohistochemistry was recently found in 27% of EGFR mutated NSCLC with acquired resistance to EGFR TKI [17]. The gene discussed is MET; the disease is non-small cell lung carcinoma.